Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)

NCT02456038 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Hypophosphatasia

Interventions

DRUG: Asfotase Alfa (ALXN1215)

Sponsor

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Collaborators

[object Object]